News
J&J said on Thursday it has reached a 10-year agreement with Tokyo-based contract drug developer Fujifilm Biotechnologies for ...
The stock's fall snapped a two-day winning streak.
12h
TipRanks on MSNRegeneron and Intellia’s Gene Therapy Study for Hemophilia B: A Market Game-Changer?
Intellia Therapeutics Inc ((NTLA)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools ...
Whether it’s a cook, a home health aide, or a direct support professional, domestic workers are critical for so many people ...
U.S. pharma bounced back in Q2, and in this episode of "The Top Line," Fierce Pharma's Eric Sagonowsky and Kevin Dunleavy ...
Despite boasting a new owner, the Indiana manufacturing plant that Novo Nordisk picked up as part of its parent company's ...
The FDA has identified critical lapses at a production facility operated by Novo Nordisk that is used by several drugmakers, ...
These were among the concerns of a recent regulatory inspection of a key, but historically troubled, manufacturing plant that ...
Kodiak Sciences' pipeline, led by tarcocimab, targets less frequent dosing for retinal diseases but faces tough competition ...
18h
Zacks.com on MSNThe Zacks Analyst Blog Highlights Health Care Select Sector SPDR, SPDR S&P 500 ETF Trust, UnitedHealth, Regeneron, CVS Health and Novo Nordisk
Healthcare stocks trade at a 30-year discount, with XLV showing signs of rebound as Buffett and hedge funds boost exposure.
Fujifilm Biotechnologies is preparing to open the first phase of its massive biologics manufacturing campus in Holly Springs, North Carolina, a site designed to rank among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results